Source link : https://www.newshealth.biz/health-news/integrating-mrd-in-myeloma-guidance-for-therapy-escalation-and-de-escalation/
At the American Society of Hematology annual meeting, a roundtable discussion highlighted the evolving role of minimal residual disease (MRD) as a treatment endpoint in multiple myeloma, exploring its implications for therapy escalation, de-escalation, and discontinuation. MedPage Today brought together three expert leaders in the field: Moderator Joseph Mikhael, MD, is joined by Amrita Krishnan, […]
Author : News Health
Publish date : 2024-12-28 16:00:00
Copyright for syndicated content belongs to the linked Source.